Join the club for FREE to access the whole archive and other member benefits.
Key points from article :
FDA issued new guidelines for expedited review of stem cell and gene therapies.
Will crack down on clinics offering unproven versions of those treatments.
Only two products that qualify as gene therapy have been approved.
Patients have been blinded after fat-derived cells were injected into their eyes.
Previoulsy practitioners argued that they do not come under the agency’s jurisdiction.
Click on resource name for more details.
Ensuring safety of drugs, medical supplies and food which is used daily.
Peter Marks, M.D., Ph.D. is the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration
